Details of the Active Pharmaceutical Ingredient (API)

General Information of API (ID: D01347)
Name	Plerixafor
Synonyms	Click to Show/Hide the Synonyms of This API Plerixafor; 110078-46-1; Mozobil; AMD3100; 1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene; Amd 3100; bicyclam JM-2987; plerixafor (amd3100); Plerixafor hydrochloride; AMD-3100; SDZ SID 791; JM3100; JM 3100; 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane; JM-3100; UNII-S915P5499N; JKL 169; CHEMBL18442; 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane; S915P5499N; SID791; Plerixafor 8HCl; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]; Mozobil (TN); plerixaforum; Plerixafor [USAN:INN:BAN]; 1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane); GNA & AMD-3100; HHA & AMD-3100; JM 2987; Plerixafor(AMD3100); 1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(methylene)]bis-, hydrochloride (1:8); Plerixafor-d4 (deuterated); SCHEMBL19038; GTPL844; cc-304; Plerixafor (JAN/USAN/INN); AOB5591; DTXSID70869520; AMD-3100 (CXCR4); CHEBI:125354; BCPP000104; BCP02337; C28H54N8; EX-A1762; ANW-73610; BDBM50035696; MFCD05662218; NSC754363; NSC761388; s8030; ZINC22443609; 1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}; AKOS005266706; CCG-269710; CS-0451; DB06809; NSC-754363; NSC-761388; NCGC00165722-01; NCGC00165722-02; NCGC00165722-03; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA); AC-26837; AK-41732; AS-42504; HY-10046; AB0009909; FT-0660392; FT-0673966; A25446; D08971; S-7677; AB01566900_01; 078P461; A809618; L000104; Q905835; SR-01000941593; J-503718; SR-01000941593-1; 11''''-xylyl bis-1,4,8,11-tetraazacyclotetradecane; BRD-K33240821-367-01-8; Z2196779619; 1,1''''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}; 1,1'-(benzene-1,4-diyldimethanediyl)bis(1,4,8,11-tetraazacyclotetradecane); 1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane; 1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA); 1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane; 1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane(8HBr.2H2O); 1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane; 1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane; 11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl ester
Clinical Status	Approved
PubChem CID	65015
Formula	C28H54N8
Canonical SMILES	C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3
InChI	1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2
InChIKey	YIQPUIGJQJDJOS-UHFFFAOYSA-N
	Click to Show/Hide the Molecular Data (Structure/Property) of This API
Structure	<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=65015"></iframe>
Structure	3D MOL is unavailable		2D MOL
Physicochemical Properties	Molecular Weight	502.8	Topological Polar Surface Area	78.7
	XlogP	0	Complexity	456
	Heavy Atom Count	36	Rotatable Bond Count	4
	Hydrogen Bond Donor Count	6	Hydrogen Bond Acceptor Count	8

Full List of Drug Formulations (DFMs) Containing This API
Plerixafor 24mg/1.2ml solution		Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s)
Drug Formulation 1	DFM Info click to show the detail info of this DFM
All DIGs	Click to Show/Hide the Full List of DIGs in This DFM Sodium Chloride; Water For Injection
Dosage Form	Solution
Company	Genzyme

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.